In addition, a recent report on an attractive hypothesis on the reduction activity of the drug in the presence of albumin-rich human fluids may raise some concerns regarding the more appropriate use of this antibiotic to treat CR-Ab infections [44]. This evidence concerns the gene ALB and infection.